and adulthood (Flanders et al., 1989; Millan et al., 1991).
cytokines (Nathan and Sporn, 1991) . For example, while TGF-β is a potent inhibitor of the growth of keratinocytes Using a dominant-negative mutant receptor (DNR) in vitro, transgenic overexpression of TGF-β in the skin approach in transgenic mice, we have functionally can lead to an unexpected stimulation of keratinocyte inactivated transforming growth factor-β (TGF-β) sigproliferation in the basal state, but results in growth naling in select epithelial cells. The dominant-negative inhibition in a hyperplastic setting, following treatment mutant type II TGF-β receptor blocked signaling by with the phorbol ester TPA (Cui et al., 1995) . This all three TGF-β isoforms in primary hepatocyte and demonstrates that the physiological roles of TGF-βs in a pancreatic acinar cell cultures generated from transparticular tissue in vivo may not be readily predictable genic mice, as demonstrated by the loss of growth from its in vitro effects on cells derived from that tissue. inhibitory and gene induction responses. However, it
As one approach to the molecular dissection of the had no effect on signaling by activin, the closest in vivo biology of TGF-β, we wished to generate animal TGF-β family member. DNR transgenic mice showed models in which TGF-β function is experimentally comincreased proliferation of pancreatic acinar cells and promised in select tissues. The type I and type II TGF-β severely perturbed acinar differentiation. These results receptors (TβRI and TβRII) are activated by ligandindicate that TGF-β negatively controls growth of dependent formation of hetero-oligomeric complexes, in acinar cells and is essential for the maintenance of a which TβRII transphosphorylates and activates TβRI, differentiated acinar phenotype in the exocrine panthereby initiating the signal transduction cascade (Wrana creas in vivo. In contrast, such abnormalities were not et al., 1994) . In order to eliminate the TGF-β response in observed in the liver. Additional abnormalities in the target tissues, we have used transgenic overexpression of pancreas included fibrosis, neoangiogenesis and mild a dominant-negative mutant form of the TβRII (Brand macrophage infiltration, and these were associated et al., 1993; Chen et al., 1993) , resulting in tissue-restricted with a marked up-regulation of TGF-β expression functional inactivation of the TGF-β receptor complex.
in transgenic acinar cells. This transgenic model of
This approach of local functional inactivation of genes targeted functional inactivation of TGF-β signaling has attractive advantages when compared with germline provides insights into mechanisms whereby loss of null mutations generated by gene targeting. First, loss of TGF-β responsiveness might promote the carcinogenic function can be targeted to specific cells in selected organs process, both through direct effects on cell proliferation, with appropriate transcriptional control elements, and and indirectly through up-regulation of TGF-βs with potential embryonic lethality can be circumvented. associated paracrine effects on stromal compartments.
Introduction
inflammation observed in multiple organs of the TGF-β1 null mouse (Kulkarni et al., 1993) can be avoided. The transfoming growth factors-βs (TGF-β) are multifuncWe report here the effects of functional inactivation of tional cytokines which regulate cell growth, differentiation TGF-β in target tissues in mice with expression of a and function , and recent eviddominant-negative mutant TβRII (DNR) under control of ence suggests that they constitute part of an important tumor suppressor pathway (Markowitz and Roberts, 1996) . a metallothionein 1 (MT1) promoter (Palmiter et al., 1993) . The results show that TGF-β negatively controls growth of pancreatic acinar cells and is essential for the maintenance of a differentiated acinar phenotype in the exocrine pancreas in vivo. Furthermore, loss of TGF-β responsiveness in DNR-positive acinar cells results in an unexpected increase in expression of TGF-β1 and TGF-β3 in vivo in the exocrine pancreas. This is associated with classic correlates of TGF-β overexpression such as fibrosis, angiogenesis and macrophage infiltration. These results have implications for understanding the complex roles of the TGF-β system in tumorigenesis.
Results

Generation of DNR transgenic mice and analysis of expression
The DNR transgene encodes the extracellular and transmembrane domains of TβRII and was expressed under control of a mouse MT1 promoter and MT locus control regions (LCRs) ( Figure 1A ) (Palmiter et al., 1993) . We generated two lines of transgenic mice, line AM3 with three copies, and line BF1 with one copy per haploid genome, respectively, in the strain FVB/N. Northern blotting revealed DNR RNA expression in both lines. In line AM3, the highest zinc-induced levels of DNR RNA were observed in the pancreas, liver, colon and small intestine ( Figure 1B ). Kidney, stomach and salivary gland had substantially lower levels of expression ( Figure 1B ). DNR expression was consistently lower in tissues from line BF1 mice when compared with line AM3 tissues ( Figure 1C ). In liver and pancreas, substantial levels of DNR were expressed without zinc induction ( Figure 1C ). To show the cellular localization of DNR protein in situ, (20 μg) of tissues from 2-month-old control littermate (-) and transgenic mice (ϩ) maintained on drinking water containing 25 mM Figure 3C ). However, activin inhibited endogenous receptors ( Figure 3A) . In hepatocyte lysates
Dominant-negative mutant function of DNR in
[ 3 H]thymidine incorporation in transgenic acinar cells from line AM3, a prominent complex of~40 kDa repre-( Figure 3C ), indicating that DNR expression only inactivsented DNR bound to [ 125 I]TGF-β1, as confirmed by ates TGF-β signaling, but not signaling by other members immunoprecipitation of affinity-labeled lysates with antiof the TGF-β superfamily. Primary hepatocytes from human TβRII(1-28) ( Figure 3A) . Analogous experiments control FVB/N mice were growth inhibited by TGF-β showed similar results using primary acinar cell preparisoforms ( Figure 3D ), but not by activin (data not shown). ations ( Figure 3B) .
None of the three TGF-β isoforms inhibited growth of hepatocytes from line AM3 ( Figure 3D ). In addition, Loss of TGF-β responsiveness. Primary pancreatic acinar cell cultures from control FVB/N mice showed a marked induction of fibronectin protein secretion by TGF-β1, as seen in FVB/N hepatocytes, was absent in line AM3 inhibition of [ 3 H]thymidine incorporation when treated with either TGF-β1, TGF-β2, TGF-β3 or activin, a member hepatocytes ( Figure 3E ). These results indicate that DNR expression in cells from transgenic mice completely abroof the TGF-β superfamily structurally closely related to TGF-β ( Figure 3C ). In contrast, TGF-β isoforms had no gates both the growth inhibition mediated by the three TGF-β isoforms, and the TGF-β mediated induction of with the absence of DNR expression in endocrine cells. The abnormalities in the exocrine pancreas were generally matrix-associated genes. more severe and occurred at a younger age in line AM3 when compared with line BF1, consistent with increased Phenotypic characterization of transgenic DNR mice levels of DNR expression in the AM3 pancreas ( Figure  1C ). We focused therefore on line AM3 for a detailed On macroscopic inspection, the pancreas of line AM3 mice of 5 months and older had a lighter color when analysis of the phenotype in the pancreas. The earliest feature of the phenotype was the appearance compared with the pancreas from non-transgenic littermates. Relative pancreatic weight expressed as a percentof aberrant non-acinar cells in the exocrine pancreas from 3 weeks of age. These cells increased progressively in age of total body weight was significantly decreased in line AM3 mice when compared with FVB/N mice at 8 number and formed primitive ductular structures (Table I ; Figure 4B ). Strong staining with AE1/AE3 antibody, a months of age (0.82 Ϯ 0.10% versus 1.08 Ϯ 0.03%, P Ͻ0.05). All other organs including the liver, colon and marker of ductal epithelium, was observed in most of the aberrant non-acinar cells, confirming their ductal cell small intestine were macroscopically normal.
Histological analysis of the pancreas showed severe phenotype ( Figure 4D ). In addition, acinar cells in line AM3 mice were progressively replaced by adipose cells abnormalities, including ductular transformation, neoangiogenesis, inter-and intralobular fibrosis and adipose (Table I ; Figure 4F ). Tubular complexes, reflecting acinoductular metaplasia (Bockman, 1981) , were found in some replacement of acini in the exocrine pancreas of both transgenic lines AM3 and BF1 (see Table I ; Figures 4 and younger line AM3 mice and appeared frequently in older transgenic mice, often transforming entire lobules (Table I ; 5). The islets of Langerhans appeared normal, consistent cells, considered a marker of focal hyperplasia in rats (Eustis et al., 1990) . Eosinophilic foci were not observed and BF1, the severity of the described abnormalities correlated well with the level of DNR expression in in non-transgenic FVB/N mice (n ϭ 12), but were found in 21% (7/33) (P ϭ 0.001) of line AM3 pancreas ( Figure 4H ). affected lobules. Older animals (Ͼ14 months) were also examined for the presence of eosinophilic foci of acinar To better define the abnormalities in the transgenic pancreas, we applied specific staining techniques. Inter-N mice (18.6 Ϯ 5.8% versus 3.5 Ϯ 0.5% reticulin-stained section surface, respectively; P Ͻ0.05) ( Figure 5A and and intralobular fibrosis developed by 5 months of age in line AM3 mice, and increased progressively (Table I) . B). Consistent with this, RNA expression levels of collagen 1, fibronectin and tissue inhibitor of metalloproteinase 1 Reticulin staining of pancreas sections for collagen demonstrated significant expansion of the extracellular matrix in (TIMP-1) were increased in line AM3 pancreas when compared with non-transgenic pancreas at 1, 3, 6 and 10 8-month-old line AM3 mice when compared with FVB/ months of age (data not shown). Increased angiogenesis in line AM3 pancreas, but not in FVB/N pancreas (Table (see also Figure 4B ) and macrophage infiltration were II; Figure 6C and D). The aberrant ductular epithelial cells revealed by immunostaining for von Willebrand factor VIII present in line AM3 pancreas showed no evidence of ( Figure 5D ) and Mac-2 antigens (Figure 5F ), respectively.
increased proliferative activity, as demonstrated by the low frequency of PCNA staining in these cells (1.2 Ϯ TGF-β regulates growth and affects differentiation 0.4% at 6 weeks of age), when compared with acinar cells of acinar cells in the exocrine pancreas in vivo (35.0 Ϯ 5.1% at 6 weeks of age) ( Figure 6A ). These Proliferation and apoptosis. To address possible mechanresults indicated that inactivation of TGF-β signaling in isms underlying the observed pancreatic phenotype, we acinar cells causes an increase in proliferation and analyzed proliferative and apoptotic rates in the pancreas.
apoptosis throughout adult life in transgenic mice. In Immunohistochemistry for proliferating cell nuclear anticontrast, rates of proliferation and apoptosis in the liver gen (PCNA) demonstrated a large increase in the proporwere not significantly different between line AM3 mice tion of acinar cells in cell cycle in line AM3 pancreas and FVB/N littermates (data not shown). when compared with control FVB/N pancreas at 6 weeks Differentiation and dedifferentiation. The accumulation (Table II; Figure 6A and B) and 8 months of age (Table II) . This was accompanied by large numbers of apoptotic cells of largely non-proliferating ductular cells and duct-like 8). However, TGF-β1 protein was markedly increased in acinar cells and aberrant non-acinar cells, and TGF-β3 protein was markedly increased exclusively in acinar cells in the pancreas of line AM3 (Figure 8 ). TGF-β2 staining was not changed (Figure 8 ). These results suggest that inactivation of TGF-β signaling in acinar cells in vivo leads to increased expression of TGF-β1 and TGF-β3 isoforms.
Discussion
Using a dominant-negative mutant receptor approach in transgenic mice, we have demonstrated for the first time the feasibility of inactivating TGF-β in select tissues in the whole animal. Specifically, we have shown that TGFβs play an essential role in maintaining epithelial homeostasis and the differentiated phenotype in the exocrine gene induction in response to any of the three TGF-β Ethidium bromide-stained agarose gel demonstrating 28S and 18S ribosomal complexes.
isoforms, growth inhibition induced by activin, the TGF-β superfamily member most closely related to TGF-β, was not affected. This confirms that the dominant-negative structures with the loss of acini suggested that normal differentiation and/or maintenance of a differentiated effect of this construct is confined to TGF-β1, 2 and 3. phenotype were disturbed in the transgenic pancreas. Toluidine blue staining of semi-thin (0.5 μm) sections of Mechanisms underlying the disruption of homeostasis line AM3 pancreas showed that acini were replaced by ductular structures harboring transitional cells, characterOur data clearly indicate that TGF-β is an essential negative regulator of pancreatic acinar cell growth in vivo, ized by ductal morphology, but containing zymogen granules ( Figure 6E ). Within the same structure, cells with consistent with in vitro data (Logsdon et al., 1992) . We observed no changes in hepatocyte proliferation, apoptosis remnant acinar morphology were present ( Figure 6E ). Dedifferentiation of acini into ductal structures as so-called or collagen deposition in vivo in the liver of DNR transgenic mice when compared with normal mice, despite 'tubular complexes' has been described in association with neoplastic and inflammatory conditions in the pancreas total loss of responsiveness to TGF-β in DNR transgenic hepatocytes in vitro. This suggests that TGF-β may not (Bockman, 1981) . Tubular complexes were present in severely affected pancreatic lobules in line AM3 mice be a direct inhibitor of hepatocyte proliferation in the normal liver, and that the relative contribution of endowith increasing age (Table I; Figure 4G ). These findings suggest that inactivation of TGF-β signaling in acinar genous TGF-βs to epithelial homeostasis may vary from organ to organ. Since it has been shown that transgenic cells in vivo is associated with dedifferentiation of acini into duct-like structures and tubular complexes. In addioverexpression of active TGF-β1 in the liver can suppress the early proliferative response after partial hepatectomy tion, ductal cells may accumulate in association with high rates of acinar cell turnover (see Table II ) in the transgenic (Böttinger et al., 1996) , it is possible that TGF-β may play a role in growth control in the liver when proliferative pancreas.
homeostasis is perturbed. We are currently investigating this possibility. However, it is also possible that, despite Inactivation of TGF-β signaling results in a selective increase of expression of TGF-β isoforms the in vitro data, in vivo expression of the DNR construct in hepatocytes may not be adequate to inactivate the Because increased expression of matrix-associated genes and angiogenesis in vivo have been associated with function of TβRII. Concomitant with increased proliferation, we observed increased TGF-β activity (Roberts et al., 1986) , we examined levels of expression of TGF-β isoforms. By increased apoptosis in the transgenic acini throughout adult life. Induction of apoptosis has been shown to Northern blot analysis, expression of TGF-β1 and TGF-β3 RNA were markedly increased in line AM3 pancreas, accompany enhanced cell proliferation resulting from many forms of perturbation of the cell cycle, including and TGF-β2 RNA levels were slightly increased ( Figure  7A ). Similar results were obtained at 1, 2, 6 and 10 oncogene expression or inactivation of negative regulators of the cell cycle (Evan et al., 1992; Jacks et al., 1992 ; months of age. When compared with primary acinar cells from FVB/N control littermates, primary acinar cells from Howes et al., 1994; Naik et al., 1996; White, 1996) . Since TGF-β actually induces apoptosis in many epithelial cell line AM3 mice had increased levels of TGF-β1 RNA ( Figure 7B ). Immunostaining with TGF-β isoform-specific types (Oberhammer et al., 1992; Hsing et al., 1996) , the increased apoptosis observed in DNR-positive acini most antibodies showed little staining for TGF-β1, TGF-β2 and TGF-β3 in the exocrine pancreas of FVB/N mice ( Figure  likely represents an appropriate response to the abnormal The increased numbers of primitive ductules in the types with features of both acinar and ductal morphology ( Figure 6 ). Similar intermediate cell types consistent with transgenic pancreas at all ages, and the presence of tubular complexes, suggest that loss of negative growth regulation acinoductular retrodifferentiation have been seen using ultrastructural analysis in the pancreas of MT-TGF-α by TGF-β in the acinar cells may be incompatible with the acquisition or maintenance of the differentiated phenotransgenic mice (Bockman and Merlino, 1992) . Second, the affected lobules in the transgenic animals are charactertype. It is well documented that acinar cells, which derive from ductal cells during normal development (Githens, ized by a net loss of acinar cells, despite greatly increased proliferation in the acinar compartment. In contrast, a net 1993), can retrodifferentiate into cells with the ductal phenotype, forming ductules and tubular complexes in gain of ductular cells occurs in these lobules without increased proliferation in the ductal compartment. These experimental models and human diseases associated with abnormal growth in the pancreas (Logsdon, 1995) . Furtherobservations are most consistent with acinoductular metaplasia. It should be emphasized here that the ductular more, when acinar cells are stimulated to grow in vitro, they dedifferentiate into a more fetal-like phenotype with cells do not express the DNR transgene. Dedifferentiated ductular cells in tubular complexes of pancreas of MTductal characteristics, while on cessation of growth, differentiated acinar markers are re-acquired (De Lisle and TGF-α transgenic mice also fail to express transgenic TGF-α, suggesting that the MT1 promoter is not expressed Logsdon, 1990) . Thus acinar dedifferentiation can be a direct consequence of increased proliferation in this normin ducts and ductules (Jhappan et al., 1990) . Hence, these cells may re-acquire responsiveness to TGF-β-mediated ally quiescent compartment.
Several lines of evidence support the conclusion in our growth inhibition. Finally, the absence of inflammation or necrosis in most of the affected lobules suggests that transgenic model that the abnormally proliferating acinar increased acinar proliferation and dedifferentiation result on adjacent, TGF-β-responsive stromal tissue. Clearly, it from loss of TGF-β function in the DNR transgenic will be important to determine whether the up-regulation pancreas, rather than as a secondary consequence of other of TGF-β that we see in the pancreatic acinar cells when pathologic changes.
TGF-β responsiveness is abolished, is also observed in Replacement of pancreatic acini within lobules by other cell types. adipose tissue is often observed in humans and animals accompanying atrophy of acini from any cause including Implications for pancreatic cancer aging (Seifert, 1984; Eustis et al., 1990) . In the DNR Our observations of perturbed proliferation and differentitransgenic pancreas, where acinar homeostasis is severely ation in the transgenic pancreas may have important disturbed by abnormal proliferation, differentiation and implications for our understanding of pancreatic carcinoapoptosis, the sometimes dramatic replacement of acini genesis in humans. Pancreatic cancers in humans exhibit by intralobular adipose tissue is probably a non-specific ductal morphology in most cases, but it is controversial consequence of the resulting acinar atrophy, and not whether the duct cell is the origin of pancreatic cancer. directly related to loss of TGF-β function.
Tumors with ductal morphology in several rodent models of pancreatic carcinogenesis may have their origin in TGF-β autoregulation and carcinogenesis hyperproliferative and dysplastic acinar cells (Flaks, 1984 ; Profound changes were observed in the stromal compart- Scarpelli et al., 1984) . Recent studies using transgenic ment of the DNR transgenic pancreas, including neoangiomice with overexpression of mitogenic oncogenes such genesis, fibrosis and low-level infiltration by macrophages.
as TGF-α, c-myc and SV40 T antigen in acinar cells All these are similar to changes seen in other systems directly support the potential of acinar cells to form tumors when TGF-β activity is increased (Roberts et al., 1986;  with ductal characteristics (Ornitz et al., 1987; Jhappan Pierce et al., 1989) , and consistent with the fibrosis and Sandgren et al., 1990 Sandgren et al., , 1991 . Furthermore, cellular infiltrates observed in the exocrine pancreas of cells of mixed acinar-ductular morphology have been mice transgenic for TGF-β1 expressed under the control observed in human pancreatic carcinoma specimens (Parsa of an insulin promoter (Lee et al., 1995) . We therefore et al., 1985) . These data are consistent with the hypothesis examined the pancreas for expression of the three isoforms that pancreatic cancer could arise from dedifferentiated of TGF-β and found strikingly increased levels of TGFacinar cells (Logsdon, 1995) . Thus loss of TGF-β function β1 and TGF-β3 in transgenic acinar cells, indicating and associated acinar dedifferentiation may represent a first that inactivation of TGF-β signaling results in increased step on the pathway to pancreatic neoplasia. Interestingly, expression of TGF-β1 and TGF-β3 in these cells.
recent genetic studies have shown that Ͼ50% of pancreatic Previous in vitro studies in several TGF-β-responsive cancers in humans have defects in the gene DPC-4 (Hahn epithelial and fibroblast cell lines have indicated complex et al., 1996) , which encodes an Mad-related protein patterns of auto-and cross-regulation among TGF-β isoinvolved in TGF-β signaling (Lagna et al., 1996; Zhang forms (Bascom et al., 1989; Kim et al., 1990) . Here we et al., 1996) . Furthermore, expression of TβRI was attenushow for the first time in vivo that lack of response to ated in some pancreatic cancers with resistance to TGF-TGF-β and overexpression of TGF-β may be mechan-β-mediated growth inhibition (Baldwin et al., 1996) . This istically related, and this may have important implications is further evidence for the critical role which TGF-β plays for understanding the roles of the TGF-β system at in pancreatic homeostasis. different stages in the carcinogenic process. While TGF-β Eosinophilic foci of acinar cells were observed in a is a growth inhibitor for most epithelia (Roberts and significant number (21%) of DNR mice. In rats, eosino- , and transgenic overexpression of TGF-β philic foci indicate acinar cell hyperplasia and may repreprotects the mammary gland from tumorigenesis induced sent early stages of the neoplastic process (Eustis et al., by chemical carcinogens or oncogenes (Pierce et al., 1995; . Hence, eosinophilic foci exclusively found in G.Merlino, J.Jakubczak and G.Smith, unpublished data), pancreas of DNR mice may represent early hyperplastic expression of TGF-β isoforms is actually increased in lesions with potential for malignant progression. The lack many advanced human cancers (Gorsch et al., 1992;  Friess of such neoplastic progression in the pancreas of DNR et al., 1993; Gold and Korc, 1994; Gold et al., 1994) . The transgenic mice, despite persistent hyperproliferation, elevated TGF-β is proposed to promote tumor progression, focus formation and dedifferentiation in TGF-β-unresponsprimarily through paracrine effects on stromal elements, ive acini, indicates that additional defects may be required such as increased angiogenesis and decreased immune for carcinogenesis to proceed. Alternatively, it may reflect surveillance. These observations are reconciled by the the fact that transgene expression is lost when the cells hypothesis that the TGF-β system has tumor suppressor dedifferentiate to a ductular morphology, and the growth activity early in tumorigenesis when the TGF-β response inhibitory response is restored. However, mice bitransgenic is intact, but has oncogenic effects later if the TGF-β for both the DNR and the hepatocyte growth factor (HGF) response in the tumor cell is lost.
in the acinar cells do develop pancreatic cancer, which Recently, it has been shown that TβRII is inactivated is not seen in mice expressing either transgene alone or deleted in several different types of human tumor (J.L.Jakubczak and G.Merlino, unpublished data). These (Markowitz and Roberts, 1996) . Our data suggest this preliminary results indicate that loss of TGF-β function may have two deleterious consequences, namely (i) loss in the exocrine pancreas may enhance susceptibility to of response of the tumor cell to the growth inhibitory tumorigenesis, and that the DNR transgenic mice may effects of TGF-β, and (ii) consequent up-regulation of the represent a useful model for studying the role of TGF-β expression of TGF-β protein, which can then further promote tumorigenesis through unwanted paracrine effects in pancreatic carcinogenesis in vivo.
using an indirect immunoperoxidase detection protocol (Vectastain Elite
Materials and methods
kit, Vector Laboratories). DNR was detected in ethanol-fixed tissue sections after antigen retrieval with microwave treatment by polyclonal Construction of plasmids and transgenic mice anti-human TβRII (residues 1-28) (Upstate Biotechnology). All the Human TβRII sequences between nucleotides -7 and ϩ573, encoding following staining was performed on 10% formaldehyde-fixed tissue extracellular and transmembrane domains followed by a stop codon at sections. TGF-β1 was detected with the rabbit polyclonal antibody LC(1-the 3Ј end, were generated by PCR, ligated into the pCR vector 30) (Flanders et al., 1989) . TGF-β2 and β3 were detected with rabbit (Invitrogen) to generate the construct pCRDNR and sequenced in their polyclonal antibodies TGF-β2(50-75-2) (Flanders et al., 1990) and TGFentirety. A 600 bp EcoRI fragment of pCRDNR containing DNR cDNA β3(50-60-3) (Flanders et al., 1991) . PCNA was detected by mouse was blunt-ended and subcloned into the NruI site of pMT-LCR2999B4 monoclonal antibody PC10 (Dako). Macrophage glycoprotein Mac-2 (Palmiter et al., 1993) to generate pMT-LCR-DNR. Expression of the was detected by mononclonal anti-Mac-2 antibody (ATCC). AE1/AE3 transgene is driven by a mouse MT1 promoter, and regulated by the antibody (BioGenex Laboratories) was used to detect cytokeratins 1-8, presence of MT LCRs (Palmiter et al., 1993) . A 19.1 kb SalI 14, 15, 16 and 19. von Willebrand factor was detected with a LCR-DNR linear fragment ( Figure 1A ) was isolated and used for polyclonal anti-factor VIII antibody (Dako). For cytokeratin and von microinjections of zygote pronuclei. Transgenic mice were generated Willebrand factor staining, antigen retrieval was performed by treating using inbred FVB/N zygotes as described previously (Jhappan et al., sections for 12 min with 0.1% trypsin and 0.1% calcium chloride in 1990). Of 19 mice born, two were positive for MT-LCR-DNR and were Tris-buffered saline (TBS). bred into lines AM3 and BF1. Both lines displayed autosomal inheritance of the transgene. Tail genomic DNA was prepared and tested either by Southern blotting (founder mice) or PCR analysis (subsequent generaIn vivo proliferation and apoptosis tions) (Jhappan et al., 1990) . Animals were cared for in accordance with PCNA-positive acinar cells per high power field (HPF) (0.07 mm 2 ) were NIH guidelines. When indicated, the activity of the MT1 promoter was counted. The mean of 10 fields was calculated and the number of PCNAinduced by maintaining the animals on drinking water containing positive acinar cells/mm 2 computed. In some animals, the ratio of PCNA-25 mM ZnSO 4 .
positive and total number of acinar cells was calculated. The percentage of proliferating ductular cells in line AM3 pancreas represents the RNA analysis average ratio of the number of PCNA-positive and total ductular cells RNA was isolated from mouse tissues by guanidium isothiocyanate counted in 10 HPFs (0.07 mm 2 ) per pancreas. Apoptotic cells were extraction and column purification using the RNeasy kit (Qiagen) as identified on H&E-stained slides by a combination of pyknotic nucleus described . For Northern blot analysis, and condensed eosinophilic cytoplasm. A collection of apoptotic debris RNA was electrophoresed on 1% agarose gels and transferred to a filter.
phagocytosed by another cell was counted as a single apoptotic cell. Filters were then hybridized with 32 P-labeled probes: human TβRII from
Milder changes of apoptosis such as cytoplasmic condensation and pCRDNR, mouse TGF-β1, mouse TGF-β2 and mouse TGF-β3.
clumped hyperchromatic chromatin were not counted. Apoptotic cells per HPF (0.2 mm 2 ) were counted in 20 fields. The mean of apoptotic cells in 20 HPFs was used to compute the number of apoptotic cells/ Preparation of pancreatic acini and primary hepatocyte mm 2 . In addition, we assessed apoptosis in the liver using a TUNEL cultures labeling method (Trevigen). Pancreatic acini were isolated from adult non-transgenic FVB/N and line AM3 mice as described (Logsdon and Williams, 1983) . For proliferation studies, insulin (1 μM) and epidermal growth factor (1 nM) were added to the culture medium. Hepatocytes were isolated from
